statistiche ricercatore

Continente	#
NA - Nord America	1.148
AS - Asia	844
EU - Europa	813
SA - Sud America	66
AF - Africa	27
OC - Oceania	15
Continente sconosciuto - Info sul continente non disponibili	2
Totale	2.915

Nazione	#
US - Stati Uniti d'America	1.085
GB - Regno Unito	292
CN - Cina	261
SG - Singapore	243
IT - Italia	123
VN - Vietnam	107
DE - Germania	82
SE - Svezia	72
HK - Hong Kong	61
CA - Canada	57
RU - Federazione Russa	51
BR - Brasile	50
FR - Francia	41
BD - Bangladesh	35
FI - Finlandia	30
IN - India	30
NL - Olanda	26
IE - Irlanda	24
JP - Giappone	20
TR - Turchia	18
KR - Corea	16
AU - Australia	15
ID - Indonesia	15
DK - Danimarca	14
BE - Belgio	10
CI - Costa d'Avorio	10
RO - Romania	9
TW - Taiwan	9
PL - Polonia	7
AT - Austria	6
CH - Svizzera	6
EG - Egitto	6
UA - Ucraina	6
IQ - Iraq	5
AR - Argentina	4
CL - Cile	4
GR - Grecia	4
IR - Iran	4
MX - Messico	4
BO - Bolivia	3
IL - Israele	3
LT - Lituania	3
ZA - Sudafrica	3
EC - Ecuador	2
MA - Marocco	2
MY - Malesia	2
PH - Filippine	2
PK - Pakistan	2
SA - Arabia Saudita	2
TH - Thailandia	2
TN - Tunisia	2
UZ - Uzbekistan	2
VE - Venezuela	2
A2 - ???statistics.table.value.countryCode.A2???	1
AE - Emirati Arabi Uniti	1
AZ - Azerbaigian	1
BG - Bulgaria	1
CR - Costa Rica	1
DO - Repubblica Dominicana	1
DZ - Algeria	1
ES - Italia	1
ET - Etiopia	1
EU - Europa	1
HR - Croazia	1
KE - Kenya	1
KZ - Kazakistan	1
MU - Mauritius	1
NO - Norvegia	1
NP - Nepal	1
OM - Oman	1
PE - Perù	1
PT - Portogallo	1
RS - Serbia	1
SK - Slovacchia (Repubblica Slovacca)	1
Totale	2.915

Nome	#
PEPTIDE-CONJUGATED MORPHOLINO OLIGOMERS FOR TREATMENT OF SPINAL MUSCULAR ATROPHY	443
Is spinal muscular atrophy a disease of the motor neurons only: pathogenesis and therapeutic implications?	296
iPSC-Based Models to Unravel Key Pathogenetic Processes Underlying Motor Neuron Disease Development	285
Morpholino-mediated SOD1 reduction ameliorates an amyotrophic lateral sclerosis disease phenotype	276
CSF transplantation of a specific iPSC-derived neural stem cell subpopulation ameliorates the disease phenotype in a mouse model of spinal muscular atrophy with respiratory distress type 1	265
Therapeutic Development in Amyotrophic Lateral Sclerosis	227
Genome-wide RNA-seq and proteomic analysis of motor neurons indicates selective cytoskeletal perturbation in Brown-Vialetto disease, partially rescued by riboflavin	216
Morpholino antisense oligomer against SOD1 for amyotrophic lateral sclerosis therapy	205
Peptide-conjugated Morpholino Oligomers for treatment of Spinal Muscular Atrophy	202
Investigation of new morpholino oligomers to increase survival motor neuron protein levels in spinal muscular atrophy	199
iPSC-derived LewisX+CXCR4+β1-integrin+ neural stem cells improve the amyotrophic lateral sclerosis phenotype by preserving motor neurons and muscle innervation in human and rodent models	166
Experimental advances towards neural regeneration from induced stem cells to direct in vivo reprogramming	149
Therapeutic applications of the cell-penetrating HIV-1 Tat peptide	113
Totale	3.042

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	27	0	0	0	0	0	0	0	0	0	0	13	14
2021/2022	253	8	21	10	15	14	22	15	14	35	28	12	59
2022/2023	292	33	47	32	38	15	39	13	15	40	5	6	9
2023/2024	203	10	11	8	10	51	29	10	14	12	10	17	21
2024/2025	445	20	40	10	52	34	34	16	38	20	43	53	85
2025/2026	920	101	46	92	69	78	75	144	47	82	81	105	0
Totale													3.042

IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca